content top

2020 KEYNOTE LECTURERS

2020 KEYNOTE LECTURERS

20th EVRS Meeting

June 04-07, 2020

Teatro Filarmonico / VERONA, ITALY

RETINA AROUND THE WORLD



Dr. Mark S. Humayun – The Relja Zivojnovic Award Receiver


 

Relja Zivojnovic Award Lecture
/06/2020 @ 12:00 – 13:00

Lecture
/06/2020 @ 15:00 – 15:30

 

Mark S Humayun is a Pakistani-American ophthalmologist, engineer, scientist, inventor and academic – the only ophthalmologist ever to be elected a member of both U.S. National Academies of Medicine and Engineering. He is a university professor with joint appointments at the Keck School of Medicine of USC and the USC Viterbi School of Engineering.

Humayun was named a recipient of the National Medal of Technology and Innovation in 2015 and received the award from U.S. President Barack Obama in 2016. The award recognizes “those who have made lasting contributions to America’s competitiveness and quality of life and helped strengthen the Nation’s technological workforce. ” Humayun co-invented the Argus Series retina implants, which are manufactured by Second Sight, and are intended to restore sight to the blind. The Argus Series implants were named by Time Magazine among the top 10 inventions of 2013.

He has more than 100 patents and patent applications, and was nominated by R&D Magazine as Innovator of the Year in 2005. He was recently nominated to the National Academy of Inventors, the highest professional distinction accorded to academic inventors.

Humayun was named director of the USC Institute of Biomedical Therapeutics (IBT) in 2012, director of the National Science Foundation BioMimetic MicroElectronic Systems Engineering Research Center, and director of the Department of Energy Artificial Retina Project. He was also inaugural director of the USC Eye Institute and interim chair of the USC Department of Ophthalmology.

Education & Career

Dr Humayun received his B.S. from Georgetown University in 1984, his M.D. from Duke University in 1989, and his Ph.D. from the University of North Carolina, Chapel Hill in 1994. He completed his ophthalmology residency at Duke Eye Center and fellowships in both vitreoretinal and retinovascular surgery at the Wilmer Ophthalmological Institute at Johns Hopkins Hospital. He stayed on as faculty at Johns Hopkins where he rose to the rank of associate professor before moving to USC in 2001.

Tenure at USC

Humayun is a clinician-researcher at the University of Southern California (USC) Eye Institute, and a professor of ophthalmology and biomedical engineering for the Keck School of Medicine of USC and USC Viterbi School of Engineering. He holds the Cornelius J. Pings Chair in Biomedical Sciences. He was named Professor of Ophthalmology, Biomedical Engineering, Cell and Neurobiology in 2001. He served as Interim Chair, Department of Ophthalmology, in 2013. He was named Inaugural Director of the USC Eye Institute in 2013. He was named Director of the USC Sensory Science Institute in 2013.

California Institute of Technology

Humayun has served as a Visiting Associate in Medical Engineering at the California Institute of Technology since 2014.

Boards of Directors

He serves on the Board of Directors for the American Society of Retina Specialists, and the Board of Directors of Replenish, Inc.

Research

Humayun’s research projects focus on the treatment of debilitating eye diseases through advanced engineering.

Argus II retinal prosthesis

Humayun co-invented the Argus II retinal prosthesis, a retinal implant designed to help patients with genetic retinitis pigmentosa. More than 30 clinical trial participants in Argus II trial launched in 2007 at sites in the U.S. and Europe. It was approved by the FDA in February 2013. The first USC Eye Institute patient received the implant post-FDA approval in June 2014, and saw light one week following activation of device.

Stem cell research

Humayun is one of two principal investigators working with USC Eye Institute researchers to study how to replace damaged retinal pigment epithelial (RPE) cells with stem cells to restore sight, a potential cure for age-related macular degeneration, the leading cause of permanent impairment of reading and fine or close-up vision among people aged 65 years and older. This research is funded by a grant from California Institute for Regenerative Medicine.

Dr. Giovanni Staurenghi – The EVRS Lecture Award Receiver


EVRS Award Lecture
/06/2020 @ 12:00 – 13:00

Lecture
/06/2020 @ 15:30 – 16:00


Prof. Giovanni Staurenghi, presently Professor of Ophthalmology is Chairman of the University Eye Clinic and Director of the Univeristy Eye Clinic Department of Biomedical and Clinical Sciente “Luigi Sacco” at “Luigi Sacco Hospital in Milan Italy

He got his degree at the University of Pavia (Italy) in 1986 and his residency at the University of Milan (Italy) in 1990. He was research fellow at the Schepens Eye Research Institute from 1991 to 1992 and Visiting Scientist at the same Institute from 1992 to 1993. He became associate professor in 1999 and full professor in 2007.

His research, publications and lectures have an important bearing on retinal degeneration; in particular his work is oriented on different types of imaging and treatment.

He has been a member of ARVO since 1988, Macula Society since 2004, Ophthalmic Photographer Society since 2006 and American Accademy of Ophthalmology since 2007. He was part of the Annual Meeting Program Committee for ARVO from 2008 to 2010.

He is a scientific advisor of the Digital Angiography Reading Center (DARC) and visiting professor and consultant for the Belfast Ophthalmic Reading Center at the Central Angiographic Resource Facility (CARF).

He is a member of the Editorial Board of IOVS.

He acts as reviewer in many international scientific journals (in alphabetical order): American Journal of Ophthalmology, Archives of Ophthalmology, British Journal of Ophthalmology, European Journal of Ophthalmology, Graefe’s Archives of Ophthalmology, International Ophthalmology, IOVS, Ophtahlmology, Ophthalmologica, Retina.

content top